Sarcoma cancers are cancers that originate from abnormal connective cell tissues. This is in contrast to carcinoma-based cancers, as carcinomas arise in the “lining” of the various body structures. Sarcoma cancers often spread quite quickly and aggressively because of their high pH levels. They are a relatively rare type of cancer, and represent roughly one percent of cancer cases reported in the west. Out of all of the Sarcoma cancers, the most commonly diagnosed cancer is the Gastronintestinal stromal tumour, also known as GIST.
There are a range of different Sarcoma cancers, and these are typically named depending on the type of tissue they grow from. There are types of Sarcoma cancers that grow from bone, types from cartilage, and types from smooth muscles. All are named to reflect this. Sarcoma cancers are also named according to the “grade”. This cancer grade is attributed as low, intermediate, or high, and relates to their malignancy and behaviour.
Those affected by Sarcoma cancers can be quite varied in background, with some types of Sarcoma cancers more common in some groups of people. People of all ages can be affected by Sarcoma cancers, with young people representing roughly half of all bone sarcoma cancer diagnoses and about a fifth of all soft tissue sarcoma cancers. Children are much more likely to experience high-level bone sarcomas than are adults. However, some types of sarcoma cancers, such as GIST, mentioned earlier, tend to occur more commonly in adults.
The treatment of Sarcoma cancers varies, with low-grade cancers tending to be treated surgically or with surgery in tandem with radiation therapy and chemotherapy. In contrast, intermediate- and high-grade Sarcoma cancer are typically treated with a rigorous combination of surgery, chemotherapy, and radiation therapy. This is because intermediate- and high-grade Sarcoma cancers are associated with rapid and malignant growth, as well as likely metastasis into other areas of the body. These rigorous treatment approaches have resulted in much higher survival rates than previously, with up to 70% of Sarcoma cancer patients now surviving the critical five year stage.
Alternative therapies may be beneficial to those looking to improve their Sarcoma cancer survival likelihood, or for those who have beaten Sarcoma cancer, and now wish to decrease their chances of a recurrence. Alternative therapies tend to focus on immune-boosting properties, and as such may help the body fight against existing cancer as well as help prevent the development of new cancers. More information about these alternative therapies can be found on this site.